Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | July 15, 2026 | July 18, 2026 |
| TORO COTTC · Entity 2699 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date July 15, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,419 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 581 · Balance 11,419 F1: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.
TORO CO
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,297 |
Ending reported balance
After 2026-06-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-09 · Exercise / conversion · Acquired 4,951 · Balance 40,248 Row 2 · 2026-06-09 · Sale · Disposed 4,951 · Balance 35,297 |
| Non-Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $47.17 · Expires 2026-11-01 | Direct | 0 |
Reported balance
After 2026-06-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-09 · Exercise / conversion · Disposed 4,951 · Balance 0 F2: The option vested in three equal annual installments commencing on the first anniversary of the date of grant, which was November 1, 2016. |
| Common Stock UnitsSEC Table I · non-derivative | Direct | 4,193.177 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,193.177 F1: Includes 35.086 common stock units acquired by the reporting person under the dividend reinvestment feature of The Toro Company Deferred Compensation Plan for Non-Employee Directors since the date of his last report. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 35.086 common stock units acquired by the reporting person under the dividend reinvestment feature of The Toro Company Deferred Compensation Plan for Non-Employee Directors since the date of his last report.
F2: The option vested in three equal annual installments commencing on the first anniversary of the date of grant, which was November 1, 2016.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (10/05/2017)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 1,024 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/07/2018)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 2,184 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-13 · Disposition to issuer · Disposed 1,762 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (02/26/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-13 · Disposition to issuer · Disposed 1,870 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Restricted Stock Units (03/11/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-13 · Disposition to issuer · Disposed 1,798 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-12-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F2: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock.
Medtronic plc
Report date December 30, 2016 · Filed January 04, 2017
Section 16 reporting ended · disclosed 2017-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 180,718 |
Reported balance
After 2016-12-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-30 · Gift · Disposed 10,000 · Balance 180,718 F1: This balance increased by 464 shares due to exempt transactions such as dividend reinvestment. |
| Ordinary SharesSEC Table I · non-derivative | Indirect401(k) | 5,294 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,294 |
| Ordinary SharesSEC Table I · non-derivative | IndirectEsop | 7,945 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 7,945 |
Filing footnotes · ownership attribution and instrument terms
F1: This balance increased by 464 shares due to exempt transactions such as dividend reinvestment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 18, 2026 01:25 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 581 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084765 · tm2620811-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,419 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 16:35 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionNon-Qualified Stock Option · Derivative | 4,951 | $0.00 Strike: $47.17 | $0.00 |
DisclosureSEC source: 0001628280-26-042114 · wk-form4_1781109322.xml · derivative · entry 4 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,951 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments commencing on the first anniversary of the date of grant, which was November 1, 2016. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 16:35 UTC | TORO CO TTC · Entity 2699 | SaleCommon Stock | 4,951 | $91.91 | $455,046.41 |
DisclosureSEC source: 0001628280-26-042114 · wk-form4_1781109322.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,297 Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 16:35 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionCommon Stock | 4,951 | $47.17 | $233,538.67 |
DisclosureSEC source: 0001628280-26-042114 · wk-form4_1781109322.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed May 4, 2026 22:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-055066 · tm2613528-8_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,838 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 518 | $52.07 | $26,972.26 |
DisclosureSEC source: 0001104659-26-044367 · tm2612028-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,276 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 304 | $96.47 | $29,326.88 |
DisclosureSEC source: 0001104659-26-005034 · tm263634-4_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,758 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 22:11 UTC | TORO CO TTC · Entity 2699 | GrantNon-Qualified Stock Option · Derivative | 2,266 | $0.00 Strike: $74.21 | $0.00 |
DisclosureSEC source: 0001628280-25-048996 · wk-form4_1762294258.xml · derivative · entry 3 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,266 Underlying: Common Stock · 2,266 shares Expires 2035-11-03 F3 · shares: Annual option grant for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan. F4 · derivative.exercise_date: The option vests in three equal annual installments commencing on the first anniversary of the November 3, 2025 grant date. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 22:11 UTC | TORO CO TTC · Entity 2699 | GrantCommon Stock | 1,235 | $74.21 | $91,649.35 |
DisclosureSEC source: 0001628280-25-048996 · wk-form4_1762294258.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,297 F1 · shares: Annual common stock award for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan. Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 372 | $78.84 | $29,328.48 |
DisclosureSEC source: 0001104659-25-100093 · tm2528856-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,454 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 221 | $128.00 | $28,288.00 |
DisclosureSEC source: 0001104659-25-068329 · tm2521079-4_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,082 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:22 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionNon-Qualified Stock Option · Derivative | 5,038 | $0.00 Strike: $37.67 | $0.00 |
DisclosureSEC source: 0000737758-25-000060 · wk-form4_1749748931.xml · derivative · entry 4 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,038 shares Expires 2025-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments commencing on the first anniversary of the date of grant, which was November 2, 2015. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:22 UTC | TORO CO TTC · Entity 2699 | SaleCommon Stock | 5,038 | $70.81 | $356,740.78 |
DisclosureSEC source: 0000737758-25-000060 · wk-form4_1749748931.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,062 Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:22 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionCommon Stock | 5,038 | $37.67 | $189,781.46 |
DisclosureSEC source: 0000737758-25-000060 · wk-form4_1749748931.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2025 Filed May 6, 2025 00:26 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 1,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-044697 · tm2514079-6_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,861 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 169 | $149.70 | $25,299.30 |
DisclosureSEC source: 0001104659-25-035497 · tm2512484-3_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 137 | $176.33 | $24,157.21 |
DisclosureSEC source: 0001104659-25-004609 · tm253739-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,426 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 16:53 UTC | TORO CO TTC · Entity 2699 | GrantNon-Qualified Stock Option · Derivative | 2,167 | $0.00 Strike: $81.50 | $0.00 |
DisclosureSEC source: 0000737758-24-000071 · wk-form4_1730825607.xml · derivative · entry 3 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2034-11-01 F3 · shares: Annual option grant for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan. F4 · derivative.exercise_date: The option vests in three equal annual installments commencing on the first anniversary of the November 1, 2024 grant date. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 16:53 UTC | TORO CO TTC · Entity 2699 | GrantCommon Stock | 1,011 | $81.50 | $82,396.50 |
DisclosureSEC source: 0000737758-24-000071 · wk-form4_1730825607.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,062 F1 · shares: Annual common stock award for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 20:20 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 115 | $210.46 | $24,202.90 |
DisclosureSEC source: 0001104659-24-109191 · tm2426283-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,289 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 154 | $138.58 | $21,341.32 |
DisclosureSEC source: 0001104659-24-080585 · tm2419668-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,174 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057571 · tm2413647-6_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,020 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 70 | $231.74 | $16,221.80 |
DisclosureSEC source: 0001104659-24-047895 · tm2411955-5_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,304 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:37 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionNon-Qualified Stock Option · Derivative | 5,192 | $0.00 Strike: $30.86 | $0.00 |
DisclosureSEC source: 0001127602-24-010490 · form4.xml · derivative · entry 4 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,192 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments commencing on the first anniversary of the December 4, 2015 grant date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:37 UTC | TORO CO TTC · Entity 2699 | SaleCommon Stock | 5,192 | $88.75 | $460,764.04 |
DisclosureSEC source: 0001127602-24-010490 · form4.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,051 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:37 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionCommon Stock | 5,192 | $30.86 | $160,225.12 |
DisclosureSEC source: 0001127602-24-010490 · form4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 87 | $186.10 | $16,190.70 |
DisclosureSEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 3 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,234 F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 8 | $150.47 | $1,203.76 |
DisclosureSEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,147 F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:46 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2 | $325.91 | $651.82 |
DisclosureSEC source: 0001104659-24-004909 · tm243653-4_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,139 F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:52 UTC | TORO CO TTC · Entity 2699 | GrantNon-Qualified Stock Option · Derivative | 2,130 | $0.00 Strike: $81.03 | $0.00 |
DisclosureSEC source: 0001127602-23-026770 · form4.xml · derivative · entry 3 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,130 Underlying: Common Stock · 2,130 shares Expires 2033-11-01 F3 · shares: Annual option grant for service as a non-employee director issued under the 2022 Plan. F4 · derivative.exercise_date: The option vests in three equal annual installments commencing on the first anniversary of the November 1, 2023, grant date. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 20:52 UTC | TORO CO TTC · Entity 2699 | GrantCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-026770 · form4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,051 F1 · shares: Annual common stock award for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan (the "2022 Plan"). Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 23:47 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 99 | $150.47 | $14,896.53 |
DisclosureSEC source: 0001104659-23-109692 · tm2328548-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,137 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:47 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 46 | $325.91 | $14,991.86 |
DisclosureSEC source: 0001104659-23-082374 · tm2321602-3_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,038 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:52 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054652 · tm2314266-9_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,992 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 64 | $231.77 | $14,833.28 |
DisclosureSEC source: 0001104659-23-044565 · tm2312581-1_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,323 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 18:48 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionNon-Qualified Stock Option · Derivative | 5,104 | $0.00 Strike: $29.23 | $0.00 |
DisclosureSEC source: 0001127602-23-011302 · form4.xml · derivative · entry 4 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,104 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments commencing on the first anniversary of the November 1, 2013 grant date. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 18:48 UTC | TORO CO TTC · Entity 2699 | SaleCommon Stock | 5,104 | $110.52 | $564,114.50 |
DisclosureSEC source: 0001127602-23-011302 · form4.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,108 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $110.390 to $110.790, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 18:48 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionCommon Stock | 5,104 | $29.23 | $149,189.92 |
DisclosureSEC source: 0001127602-23-011302 · form4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2023 Filed Jan 20, 2023 00:55 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 60 | $248.31 | $14,898.60 |
DisclosureSEC source: 0001104659-23-005113 · tm233800-3_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,259 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 18:24 UTC | TORO CO TTC · Entity 2699 | GrantNon-Qualified Stock Option · Derivative | 1,670 | $0.00 Strike: $105.12 | $0.00 |
DisclosureSEC source: 0001127602-22-024847 · form4.xml · derivative · entry 3 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 1,670 shares Expires 2032-11-01 F3 · shares: Annual option grant for service as a non-employee director issued under the 2022 Plan. F4 · derivative.exercise_date: The option vests in three equal annual installments commencing on the first anniversary of the November 1, 2022 grant date. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 18:24 UTC | TORO CO TTC · Entity 2699 | GrantCommon Stock | 939 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-024847 · form4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,108 F1 · shares: Annual common stock award for service as a non-employee director issued under The Toro Company 2022 Equity and Incentive Plan, (the "2022 Plan"). Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 20:21 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 88 | $168.98 | $14,870.24 |
DisclosureSEC source: 0001104659-22-108503 · tm2228171-4_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,199 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 22:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 77 | $193.86 | $14,927.22 |
DisclosureSEC source: 0001104659-22-079609 · tm2221003-3_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,111 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 19:32 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionNon-Qualified Stock Option · Derivative | 6,842 | $0.00 Strike: $21.56 | $0.00 |
DisclosureSEC source: 0001127602-22-017218 · form4.xml · derivative · entry 4 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,842 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments commencing on the first anniversary of the date of grant, which was November 1, 2012. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 19:32 UTC | TORO CO TTC · Entity 2699 | SaleCommon Stock | 6,842 | $83.24 | $569,514.40 |
DisclosureSEC source: 0001127602-22-017218 · form4.xml · nonDerivative · entry 2 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,169 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $83.210 to $83.265, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 19:32 UTC | TORO CO TTC · Entity 2699 | Exercise / conversionCommon Stock | 6,842 | $21.56 | $147,479.31 |
DisclosureSEC source: 0001127602-22-017218 · form4.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2022 Filed May 11, 2022 00:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 1,243 | $0.00 Strike: $211.29 | $0.00 |
DisclosureSEC source: 0001104659-22-058418 · tm2215111-5_4seq1.xml · derivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires 2032-04-28 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 28, 2023, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 08, 2022 Filed Apr 13, 2022 00:44 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 59 | $254.08 | $14,990.72 |
DisclosureSEC source: 0001104659-22-045204 · tm2212578-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,034 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 65 | $227.56 | $14,791.40 |
DisclosureSEC source: 0001104659-22-003600 · tm222681-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,975 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 20:40 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Disposition to issuerRestricted Stock Units (03/11/2021) · Derivative | 1,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-013219 · marketforms-54646.xml · derivative · entry 6 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,798 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F2 · price: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.exercise_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. F2 · derivative.expiration_date: Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.